# K233822: i2Contour

- Pathway: 510(k) (Traditional)
- Applicant: Mrimath, LLC
- Decided: Aug 8, 2024 after 251 days
- Product code: QIH (Automated Radiological Image Processing Software)
- Device class: 2
- Regulation: 21 CFR 892.2050
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K061855 (2006). 3 ancestors in all.
No later device cites it as a predicate yet.
0 of 4 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K221738: NS-HGlio, Neosoma, Inc. (2022) Summary page 5.

## Indications for use
MRI Math i2contour is intended for the semi-automatic labeling, visualization, and volumetric quantification of WHO grade 4 glioblastoma (GBM) from a set of standard MRI images of male or female patients 18 years of age or older who are known to have pathologically proven glioblastoma. Volumetric measurements may be compared to past measurements if available. MRIMath i2contour is not to be used for primary diagnosis and is not intended to be the sole diagnostic metric.

Source page: https://510kreport.com/device/K233822
Methodology: https://510kreport.com/methodology